The ACEP offices will be closed for several upcoming holidays
We apologize for any inconvenience:
Monday, December 23, 2024 thru Wednesday, January 1, 2025.
ACEP ID:
Scope of Application. This guideline is intended for physicians working in emergency departments (EDs).
Inclusion Criteria. This guideline is intended for adult patients presenting to the ED with suspected or known acute venous thromboembolism (ie, PE or DVT).
Exclusion Criteria. This guideline is not intended to address the care of pediatric patients, or those with venous thromboembolism in the setting of cardiac arrest or pregnancy.
Recommendations offered in this policy are not intended to represent the only diagnostic and management options that the emergency physician should consider. ACEP recognizes the importance of the individual physician’s judgment and patient preferences.
In adult patients with suspected acute pulmonary embolism (PE), can a clinical prediction rule be used to identify a group of patients at very low risk for the diagnosis of PE for whom no additional diagnostic workup is required?
None specified.
For patients who are at low risk for acute PE, use the Pulmonary Embolism Rule-out Criteria (PERC) to exclude the diagnosis without further diagnostic testing.
None specified.
None specified.
For patients who are at low risk for acute PE, use the Pulmonary Embolism Rule-out Criteria (PERC) to exclude the diagnosis without further diagnostic testing.
None specified.
In adult patients with low to intermediate pretest probability for acute pulmonary embolism (PE), does a negative age-adjusted D-dimer result identify a group of patients at very low risk for the diagnosis of PE for whom no additional diagnostic workup is required?
None specified.
In patients older than 50 years deemed to be low or intermediate risk for acute PE, clinicians may use a negative age-adjusted D-dimer* result to exclude the diagnosis of PE.
*For highly sensitive D-dimer assays using fibrin equivalent units (FEU) use a cutoff of age×10 μg/L; for highly sensitive D-dimer assays using D-dimer units (DDU), use a cutoff of age×5 μg/L.
None specified.
None specified.
In patients older than 50 years deemed to be low or intermediate risk for acute PE, clinicians may use a negative age-adjusted D-dimer* result to exclude the diagnosis of PE.
*For highly sensitive D-dimer assays using fibrin equivalent units (FEU) use a cutoff of age×10 μg/L; for highly sensitive D-dimer assays using D-dimer units (DDU), use a cutoff of age×5 μg/L.
None specified.
In adult patients with subsegmental pulmonary embolism (PE), is it safe to withhold anticoagulation?
None specified.
None specified.
Given the lack of evidence, anticoagulation treatment decisions for patients with subsegmental PE without associated deep venous thrombosis (DVT) should be guided by individual patient risk profiles and preferences. [Consensus recommendation]
None specified.
None specified.
Given the lack of evidence, anticoagulation treatment decisions for patients with subsegmental PE without associated deep venous thrombosis (DVT) should be guided by individual patient risk profiles and preferences. [Consensus recommendation]
In adult patients diagnosed with acute pulmonary embolism (PE), is initiation of anticoagulation and discharge from the emergency department (ED) safe?
None specified.
None specified.
Selected patients with acute PE who are at low risk for adverse outcomes as determined by Pulmonary Embolism Severity Index (PESI), simplified PESI (sPESI), or the Hestia criteria may be safely discharged from the ED on anticoagulation, with close outpatient follow-up.
None specified.
None specified.
Selected patients with acute PE who are at low risk for adverse outcomes as determined by Pulmonary Embolism Severity Index (PESI), simplified PESI (sPESI), or the Hestia criteria may be safely discharged from the ED on anticoagulation, with close outpatient follow-up.
In adult patients diagnosed with acute lower-extremity deep venous thrombosis (DVT) who are discharged from the emergency department (ED), is treatment with a Non–Vitamin K Antagonist Oral Anticoagulant (NOAC) safe and effective compared with treatment with low-molecular-weight heparin (LMWH) and vitamin K antagonist (VKA)?
None specified.
In selected patients diagnosed with acute DVT, a NOAC may be used as a safe and effective treatment alternative to LMWH/VKA.
Selected patients with acute DVT may be safely treated with a NOAC and directly discharged from the ED.
None specified.
In selected patients diagnosed with acute DVT, a NOAC may be used as a safe and effective treatment alternative to LMWH/VKA.
Selected patients with acute DVT may be safely treated with a NOAC and directly discharged from the ED.
